deltatrials
Completed NA INTERVENTIONAL 1-arm NCT02145364

Ultherapy® for the Treatment of Acne Scars

Evaluation of the Ulthera® System for Correction of Moderate to Severe Atrophic Acne Scars

Sponsor: Ulthera, Inc

Conditions Acne Scars Atrophic Acne Scars
Interventions Ultherapy® treatment
Updated 8 times since 2017 Last updated: Dec 13, 2017 Started: May 31, 2014 Primary completion: Jul 31, 2015 Completion: Oct 31, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Acne Scars and Atrophic Acne Scars, this trial is completed. The trial is conducted by Ulthera, Inc and has accumulated 8 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Dec 2017 · 10 months · monthly snapshotCompleted~Dec 2017 – ~Jun 2018 · 6 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Apr 2022 · 15 months · monthly snapshotCompleted~Apr 2022 – ~Jul 2024 · 27 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Apr 2022 — Jul 2024 [monthly]

    Completed NA

  4. Jan 2021 — Apr 2022 [monthly]

    Completed NA

  5. Jun 2018 — Jan 2021 [monthly]

    Completed NA

▶ Show 3 earlier versions

  1. Dec 2017 — Jun 2018 [monthly]

    Completed NA

  2. Feb 2017 — Dec 2017 [monthly]

    Completed NA

  3. Jan 2017 — Feb 2017 [monthly]

    Completed NA

    First recorded

May 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ulthera, Inc
Data source: Merz North America, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations